| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | 0.036 | 0.2 |
| mRNA | ISOX:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.045 | 0.2 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | 0.041 | 0.2 |
| mRNA | BMS-270394 | CTRPv2 | pan-cancer | AAC | 0.048 | 0.2 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | 0.057 | 0.2 |
| mRNA | lomeguatrib | CTRPv2 | pan-cancer | AAC | 0.048 | 0.2 |
| mRNA | BRD-K35604418 | CTRPv2 | pan-cancer | AAC | -0.048 | 0.2 |
| mRNA | neopeltolide | CTRPv2 | pan-cancer | AAC | 0.089 | 0.2 |
| mRNA | CHM-1 | CTRPv2 | pan-cancer | AAC | -0.041 | 0.2 |
| mRNA | phloretin | CTRPv2 | pan-cancer | AAC | 0.043 | 0.2 |